Safety of individualized herbal medicine for dysmenorrhea: pharmacovigilance from South Korea’s national pilot
Coverage of individually prescribed HMDs under South Korea's NHI system was not associated with elevated serious safety risks for dysmenorrhea. These findings support continued reimbursement and provide a scalable template for claims-based pharmacovigilance using standardized endpoints, routine signal detection, and feedback to benefit design and clinical practice.
Authors
- Junhyeok Yi (ORCID: https://orcid.org/0000-0001-9897-6754)
- Kyeore Bae
- Sujin Kim
- Nan-He Yoon
- Yongjoo Kim
- Minjung Park
Institutions
- Gachon University (KR)
- WonKwang Health Science University (KR)
- Korea Institute for Health and Social Affairs (KR)
- National Development Institute of Korean Medicine (KR)
- Sangji University (KR)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.3389/fphar.2026.1722249
- Primary Topic
- Menstrual Health and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00